Befiradol Fumarate

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameBefiradol Fumarate
Drug Alias Name่ด้žๆ‹‰ๅคšBefiradolumBefiradol่ด้žๆ‹‰ๆœต่ด้žๆ‹‰้†‡ +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsDyskinesias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPierre Fabre Group
China Registration ClassN/A

Develop Information

Active CompaniesNeurolixis
Inactive CompaniesN/A
Active IndicationsDyskinesias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A